CAS: 127-65-1; Sodium Chloro(Tosyl)Amide

上下游产品

CAS号70-55-3 对甲苯磺酰胺 | CAS号473-34-7 二氯胺T | CAS号1113-60-6 羟基丙酮酸 | CAS号109814-59-7 N-[diethylamino... | CAS号4083-64-1 对甲基苯磺酰异氰酸酯 | CAS号473-34-7 二氯胺T | CAS号70-55-3 对甲苯磺酰胺 | CAS号473-81-4 DL-甘油酸 | CAS号488-16-4 D-赤藓酸钾盐 | CAS号488-30-2 D-ARABINONIC ACID

专利信息

专利号:WO-2025057193-A1
优先权日:2023-09-13
标题:A method for the synthesis of substituted anthranilic amide compounds, intermediates and salts thereof
发明人：MALVIYA NITIN JAIKANT; SINGH VIPENDER; KALE MANOJ GANPAT; SHAH JIGARKUMAR HARKISHANDAS; GAVHANE KISHOR BAPU; KAVITAKE SANTOSH GIRIDHAR; BORHADE AJIT SAHEBRAO; KLAUSENER ALEXANDER G M
权利人:PI INDUSTRIES LTD
摘要:The present invention provides a method for the synthesis of compounds of formula (I), intermediates, and salts thereof, formula (I) wherein, R, R1 and n are as described in the description. The method further comprises the synthesis of anthranilic diamide compounds of formula (E), wherein the formula (E) is described in the description.

专利号:US-2023339844-A1
优先权日:2020-09-17
标题:A process for the synthesis of anthranilic acid/amide compounds and intermediates thereof
发明人：MAHAPATRA TRIDIB; PATRA PRANAB KUMAR; KLAUSENER ALEXANDER G M; MAL SANJIB; SHARMA RAJU
权利人:PI INDUSTRIES LTD; PI INDUSTRIES LTD
摘要:The present invention disclosed a process for the synthesis of compound of formula (Z) or a salt thereof, n n n n n n n n n n wherein, R, R 1 , R 2 , R 3 and R 10 are as defined in the detailed description. The process further comprises the synthesis of an anthranilic diamide compound of formula (I).

专利号:US-2023339906-A1
优先权日:2020-09-26
标 题 :A process for the synthesis of anthranilic acid/amide compounds and intermediates thereof
发明人：SYTHANA SURESH KUMAR; NAGLE PRAMOD; KUMAR VIJAY KUMAR; KANAWADE SHRIKANT BHAUSAHEB; CHANDRE TUKARAM NIVRUTTI; THUBE VINAYAK KISAN; PATIL PRADEEP PRAKASH; SHUKLA SHALINI; SHENDE KANTILAL BALU; PATRA PRANAB KUMAR; KLAUSENER ALEXANDER G M
权利人:PI INDUSTRIES LTD; PI INDUSTRIES LTD
摘要:The present invention discloses a process for the synthesis of compound of formula (VII) or a salt thereof,wherein, R, R1, R2, R3, R4a and R4b are as defined in the detailed description. The process further comprises the synthesis of an anthranilic diamide compound of formula (I).

专利号:US-2005192445-A1
优先权日:2004-03-01
标题:Semi-synthesis of taxane intermediates and aziridine analogues and their conversion to paclitaxel and docetaxel
发明人：NAIDU RAGINA
权利人:PHYTOGEN LIFE SCIENCES INC
摘要:A process is provided for the semi-synthesis of taxane intermediates and aziridine analogues of cephalomannne and baccatin III intermediates, and the conversion of such intermediates and analogues to paclitaxel and docetaxel.

专利号:EP-1724260-B1
优先权日:2005-05-06
标题:Process for the synthesis of (2S, 3aR, 7aS)octahydroindole-2-carboxylic acid and its conversion to trandolapril
发明人：AKHTAR HAIDER; RAMESH BABU POTLURI; VENKATA SUBHRAMANIAN HARIHARAK; HARI PRASSAD KODALI
权利人:SOCHINAZ SA
摘要:The present invention describes a novel method for the synthesis of (2S,3aR,7aS)-octahydroindole-2-carboxylic acid of formula III nusing a new intermediate of formula II nand conversion of the product of formula-III to trandolapril of formula I

专利号:EP-0824103-A1
优先权日:1996-08-13
标题:Method for synthesis of Tyr-3-octreotide
发明人：SU CHANG-SHINN; LEE TE-WEI; CHANG SHIANG-RONG; CHYI SHYH-YI; SHEN LIE-HANG; TSAI ZEI-TSAN
权利人:SU CHANG SHINN; LEE TE WEI; CHANG SHIANG RONG; CHYI SHYH YI; SHEN LIE HANG; TSAI ZEI TSAN
摘要:The present invention is a novel synthesis of Tyr-3-octreotidenfor radiopharmaceuticals. In this method, thenstarting material, Fmoc-Cys(Trt)-Wang Resin, is coupled withnvarious selected amino acids to form a straight chain ofnpeptide-resin compound, D-Phe-Cys(Trt)-Tyr(tBu)-D-Trp(Boc)-Lys(Boc)-Thr(tBu)-Cys(Trt)-WangnResin. This compound thennreacts with iodine to give disulfide-containing peptidenresin ofn nCleavage of the peptide from the resin is achievednby aminolysis with threoninol, the cleavaged peptide isnfurther deprotected with trifluoroacetic acid (TFA) tonobtain the crude peptide Tyr-3-octreotide of the formulan nwhich can be purified by high performance liquidnchromatography (HPLC). The final product Tyr-3-octreotidencan be labelled by radioiodine for tumor imagingnradiopharmaceuticals.